Position in URGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$4,246,731
-$4,340,914 QoQ
Shares Held
236,192
-35.6% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,536,998 across 248 Biotechnology names. URGN ranks #69 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in URGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,246,731 | 236,192 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $8,587,645 | 366,680 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,237,066 | 162,259 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $337,129 | 24,608 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $300,632 | 27,182 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $332,950 | 31,263 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $245,706 | 19,347 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $239,769 | 14,289 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $196,260 | 13,084 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $155,520 | 10,368 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $147,300 | 10,514 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $14,189 | 1,371 | Shares | Defined | 2023-08-14 | |
| 2022-03-31 | $98,231 | 11,278 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $119,235 | 12,538 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $200,292 | 11,908 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $187,407 | 12,273 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $258,187 | 13,254 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $309,005 | 17,148 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $252,774 | 13,104 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $317,670 | 12,162 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $118,242 | 6,628 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||